Growing Government Focus on Immunization Programs
The anti-infective vaccines market is predicted to develop due to a broad coalition of governments striving to raise awareness of the benefits of vaccination through immunisation programs with the goal of preventing the spread of communicable illnesses that are linked with high morbidity and mortality. For example, the ‘Immunize Australia Program’ funds individual immunisation, which serves as a preventative measure in reducing illness onset and limiting illness transmission, therefore sparing millions of Australians from serious diseases. The growing significance of government and non-government organisations in this industry is likely to give the vertical a significant boost. UNICEF and the WHO have released guidelines for developing a national immunisation plan, known as the Comprehensive Multi-Year Plan (cMYP), for all countries around the world, with the goal of ensuring equitable access to vaccination facilities for all people and increasing stakeholder participation in meeting vaccination coverage targets by designing and implementing feasible financial strategies.
Which Factors are Driving the Global Anti-Infective Vaccines Market?
• Growing Vaccination Awareness to Boost Anti-Infective Vaccines Market
• Increasing Incidence of Infectious Diseases
• Rising R&D Activities to Fuel Anti-Infective Vaccines Market Growth Through 2031
• Growing Government Focus on Immunization Programs
What are the Market Opportunities for Global Anti-Infective Vaccines Market?
• Growing Government Support to Offer Lucrative Growth Prospects
• Emerging Infectious Diseases to Offer Lucrative Growth Prospects
• Increasing Vaccine Penetration Coverage
Discover how to stay ahead
Our 370+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Anti-Infective Vaccines Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles and commercial developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
Discover sales predictions for the world market and sub-markets
Product Type
• Live/Attenuated Vaccines
• Inactivated Vaccines
• DNA & Recombinant Vector Vaccines
• Others
Disease Type
• Bacterial Diseases
– Typhoid Vaccines
– Tuberculosis Vaccines
– Tetanus & Diphtheria Vaccines
– Others
• Viral Diseases
– Influenza Vaccines
– Hepatitis Vaccines
– Polio Vaccines
– Others
Distribution Channel
• Hospitals Clinics
• Public Hospitals
• Private Clinics
• Retail Pharmacies and Drug Stores
• E-commerce
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 16 leading national markets:
By Region
• North America
– U.S.
– Canada
• Europe
– Germany
– France
– UK
– Italy
– Spain
– Russia
– Rest of Europe
• Asia Pacific
– China
– Japan
– India
– Australia
– Rest of Asia Pacific
• Latin America
– Brazil
– Mexico
– Rest of Latin America
• Middle East & Africa
– GCC
– South Africa
– Rest of Middle East & Africa
Need industry data? Please contact us today.
Leading companies and the potential for market growth
Overall world revenue for Anti-Infective Vaccines Market will surpass $xx billion in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Anti-Infective Vaccines Market report helps you
In summary, our 370+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Anti-Infective Vaccines Market, with forecasts for Product Type, Disease Type, and Distribution Channel, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets– See forecasts for the Anti-Infective Vaccines market in North America, Europe, Asia Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the companies involved in the Anti-Infective Vaccines Market. Some of the company’s profiled in this report include Evotec, Merck & Co, Inc., GlaxoSmithKline plc., Emergent BioSolutions Inc., Valneva SE, CSL Limited, Pfizer, Serum Institute of India Pvt. Ltd., BioDiem, Mitsubishi Tanabe Pharma Corporation, Sinovac Biotech Ltd., Bavarian Nordic, Berna Biotech Pharma GmbH, Hookipa Pharma Inc., and Syneos Health among other prominent players.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Anti-Infective Vaccines Market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Anti-infective Vaccines Market Report 2021-2031: Forecasts by Product Type (Live/Attenuated Vaccines, Inactivated Vaccines, DNA & Recombinant Vector Vaccines, Others), by Disease Type (Bacterial Diseases (Typhoid Vaccines, Tuberculosis Vaccines, Tetanus & Diphtheria Vaccines, Others), Viral Diseases (Influenza Vaccines, Hepatitis Vaccines, Polio Vaccines, Others)), by Distribution Channel (Hospitals, Clinics, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Anti-infective Vaccines Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Anti-Infective Vaccines Market
1.2 Anti-Infective Vaccines Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Growing Vaccination Awareness to Boost Anti-Infective Vaccines Market
3.1.2 Increasing Incidence of Infectious Diseases
3.1.3 Rising R&D Activities to Fuel Anti-Infective Vaccines Market Growth Through 2031
3.1.4 Growing Government Focus on Immunization Programs
3.2 Restraints
3.2.1 Lack of Skilled Professionals
3.2.2 Lack of Vaccination Awareness Across LMIC Economies
3.2.3 Supply Chain Disruption Amid COVID-19 to Restrain Market Growth
3.3 Opportunities
3.3.1 Growing Government Support to Offer Lucrative Growth Prospects
3.3.2 Emerging Infectious Diseases to Offer Lucrative Growth Prospects
3.3.3 Increasing Vaccine Penetration Coverage
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Industry analysis - Porter’s
3.5.1 Buyer Power
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 Industry analysis – PEST Analysis
3.6.1 Political Factors Impacting Anti-Infective Vaccines Market
3.6.2 Economic Factors Impacting Anti-Infective Vaccines Market
3.6.3 Social Factors Impacting Anti-Infective Vaccines Market
3.6.4 Technological Factors Impacting Anti-Infective Vaccines Market
4 Anti-Infective Vaccines Market by Disease Type
4.1 Bacterial Diseases Segment Market Forecast, 2021-2031
4.1.1 Rising Prevalence of Bacterial Infection Diseases to Fuel Segmental Market Growth
4.1.2 Typhoid Vaccines Market Forecast, 2021-2031
4.1.3 TB Vaccines Market Forecast, 2021-2031
4.1.4 Tetanus and Diphtheria Vaccines Market Forecast, 2021-2031
4.1.5 Others
4.1.6 Bacterial Diseases Segment Forecast, 2021-2031
4.1.7 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Viral Diseases Segment Market Forecast, 2021-2031
4.2.1 Viral Diseases Segment Accounts for Majority of the Market Share
4.2.2 Influenza Vaccines Market Forecast, 2021-2031
4.2.3 Hepatitis Vaccines Market Forecast, 2021-2031
4.2.4 Polio Vaccines Market Forecast, 2021-2031
4.2.5 Viral Diseases Segment Forecast, 2021- 2031
4.2.6 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Anti-Infective Vaccines Market by Product Type
5.1 Live/Attenuated Vaccines Segment Market Forecast, 2021-2031
5.1.1 High Demand of Disease Specific Novel Therapies to Fuel Live/Attenuated Vaccines Market Growth
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 Inactivated Vaccines Segment Market Forecast, 2021-2031
5.2.1 Rising Demand for Inactivated Vaccines from Emerging Economies to Fuel Segmental Growth
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 DNA & Recombinant Vector Vaccines Segment Market Forecast, 2021-2031
5.3.1 Technological Advancements Anticipated to Fuel Segmental Growth Through 2031
5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.4 Others Segment Market Forecast, 2021-2031
5.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Anti-Infective Vaccines Market by Distribution Channel
6.1 Hospital Clinics Segment Market Forecast, 2021-2031
6.1.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Public Hospitals Segment Market Forecast, 2021-2031
6.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.3 Private Clinics Segment Market Forecast, 2021-2031
6.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.4 Retail Pharmacies & Drug Stores Segment Market Forecast, 2021-2031
6.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.5 E-Commerce Segment Market Forecast, 2021-2031
6.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 Regional and Leading National Anti-Infective Vaccines Market Forecasts 2021-2031
7.1 Global Anti-Infective Vaccines Market by Region Forecast 2021-2031
7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 North America Anti-Infective Vaccines Market
8.1 North America Currently Dominates the Worldwide Anti-Infective Vaccines Market
8.2 North America Anti-Infective Vaccines Market by Country, Forecast 2021-2031
8.3 North America Anti-Infective Vaccines Market Forecast by Product Type
8.4 North America Anti-Infective Vaccines Market Forecast by Disease Type
8.5 North America Anti-Infective Vaccines Market Forecast by Bacterial Diseases
8.6 North America Anti-Infective Vaccines Market Forecast by Viral Diseases
8.7 North America Anti-Infective Vaccines Market Forecast by Distribution Channel
8.8 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031
8.8.1 U.S. Currently Dominates the Worldwide Anti-Infectives Market
8.8.2 Affordable Health Act to Fuel Regional Growth of Anti-Infective Vaccines Through 2031
8.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Anti-Infective Vaccines Market Forecast, 2021-2031
8.9 Canada Anti-Infective Vaccines Market Forecast, 2021-2031
8.9.1 Rising Government Initiatives to Boost Canadian Anti-Infective Vaccines Market Growth
8.9.2 Health Canada Plays a Pivotal Role in Immunization Programmes
8.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Anti-Infective Vaccines Market Forecast, 2021-2031
9 Europe Anti-Infective Vaccines Market
9.1 Rising Innovation Coupled with Numerous Research Sites to Fuel European Anti-Infectives Market Growth
9.2 Europe Anti-Infective Vaccines Market by Country, Forecast 2021-2031
9.3 Europe Anti-Infective Vaccines Market Forecast by Product Type
9.4 Europe Anti-Infective Vaccines Market Forecast by Disease Type
9.5 Europe Anti-Infective Vaccines Market Forecast by Bacterial Diseases
9.6 Europe Anti-Infective Vaccines Market Forecast by Viral Diseases
9.7 Europe Anti-Infective Vaccines Market Forecast by Distribution Channel
9.8 Germany Anti-Infective Vaccines Market Forecast, 2021-2031
9.8.1 Rising Influenza Burden to Fuel German Anti-Infective Vaccines Market Growth
9.8.2 Universal Healthcare System Anticipated to Boost German Anti-Infective Vaccines Market Growth
9.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Anti-Infective Vaccines Market Forecast, 2021-2031
9.9 France Anti-Infective Vaccines Market Forecast, 2021-2031
9.9.1 Mandatory Immunization Programmes to Fuel French Anti-Infective Vaccines Growth
9.9.2 Low Confidence in Vaccines Safety to Restrain Market Growth
9.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Anti-Infective Vaccines Market Forecast, 2021-2031
9.10 UK Anti-Infective Vaccines Market Forecast, 2021-2031
9.10.1 Seasonal Infection Burden to Demand for Anti-infective Vaccines Across UK Region
9.10.2 UK Anticipated to Remain a Key Player in EU Anti-Infective Vaccines Market
9.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Anti-Infective Vaccines Market Forecast, 2021-2031
9.11 Italy Anti-Infective Vaccines Market Forecast, 2021-2031
9.11.1 Rising Government Focus on Immunization Programmes to Boost Regional Growth
9.11.2 Economic Downturn Likely to Hamper Anti-Infective Vaccines Growth Over the Next Decade
9.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Anti-Infective Vaccines Market Forecast, 2021-2031
9.12 Spain Anti-Infective Vaccines Market Forecast, 2021-2031
9.12.1 Rising Flu Cases to Fuel Spanish Anti-Infective Vaccines Market Growth
9.12.2 Improving Economic Conditions to Boost Spanish Anti-Infective Vaccines Market Growth Through 2031
9.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Anti-Infective Vaccines Market Forecast, 2021-2031
9.13 Russia Anti-Infective Vaccines Market Forecast, 2021-2031
9.13.1 Seasonal Flu Instances to Augur Anti-Infective Vaccines Market Growth Through 2031
9.13.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Anti-Infective Vaccines Market Forecast, 2021-2031
9.14 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031
9.14.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031
10 Asia Pacific Anti-Infective Vaccines Market
10.1 Asia Pacific Anti-Infective Vaccines Market to Witness Highest Growth Rate Through 2031
10.2 Asia Pacific Anti-Infective Vaccines Market by Country, Forecast 2021-2031
10.3 Asia Pacific Anti-Infective Vaccines Market Forecast by Product Type
10.4 Asia Pacific Anti-Infective Vaccines Market Forecast by Disease Type
10.5 Asia Pacific Anti-Infective Vaccines Market Forecast by Bacterial Diseases
10.6 Asia Pacific Anti-Infective Vaccines Market Forecast by Viral Diseases
10.7 Asia Pacific Anti-Infective Vaccines Market Forecast by Distribution Channel
10.8 China Anti-Infective Vaccines Market Forecast, 2021-2031
10.8.1 China Currently Dominates the APAC Anti-Infective Vaccines Market
10.8.2 Low Confidence Towards Domestic Vaccines to Hamper Chinese Anti-Infective Vaccines Growth
10.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Anti-Infective Vaccines Market Forecast, 2021-2031
10.9 Japan Anti-Infective Vaccines Market Forecast, 2021-2031
10.9.1 Seasonal Flu Outbreaks to Fuel Japanese Anti-Infective Vaccines Growth
10.9.2 Presence of Large Vaccine Gap to Fuel Japanese Anti-Infective Vaccines Market Growth
10.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Anti-Infective Vaccines Market Forecast, 2021-2031
10.10 India Anti-Infective Vaccines Market Forecast, 2021-2031
10.10.1 India Anticipated to Witness Highest Growth Across APAC Region
10.10.2 Great Potential for Anti-Infective Vaccine Manufacturers Across the Indian Region
10.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Anti-Infective Vaccines Market Forecast, 2021-2031
10.11 Australia Anti-Infective Vaccines Market Forecast, 2021-2031
10.11.1 Rising Government Support to Fuel Australian Anti-Infective Vaccines Market Growth
10.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Anti-Infective Vaccines Market Forecast, 2021-2031
10.12 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031
10.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031
11 Latin America Anti-Infective Vaccines Market
11.1 Brazil Anticipated to Fuel LATAM Anti-Infective Vaccines Market Growth Through 2031
11.2 Latin America Anti-Infective Vaccines Market by Country, Forecast 2021-2031
11.3 Latin America Anti-Infective Vaccines Market Forecast by Product Type
11.4 Latin America Anti-Infective Vaccines Market Forecast by Disease Type
11.5 Latin America Anti-Infective Vaccines Market Forecast by Bacterial Diseases
11.6 Latin America Anti-Infective Vaccines Market Forecast by Viral Diseases
11.7 Latin America Anti-Infective Vaccines Market Forecast by Distribution Channel
11.8 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031
11.8.1 Government Focus on Immunization Programmes to Boost Brazilian Anti-Infective Vaccines Market Growth
11.8.2 Continuous Development of Brazilian Universal Healthcare System to Fuel Regional Growth
11.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Anti-Infective Vaccines Market Forecast, 2021-2031
11.9 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031
11.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Anti-Infective Vaccines Market Forecast, 2021-2031
11.10 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031
11.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031
12 Middle East and Africa Anti-Infective Vaccines Market
12.1 MEA Anticipated to Offer Immense Growth Prospects Over the Forecast Period
12.2 Middle East and Africa Anti-Infective Vaccines Market by Country, Forecast 2021-2031
12.3 Middle East and Africa Anti-Infective Vaccines Market Forecast by Product Type
12.4 Middle East and Africa Anti-Infective Vaccines Market Forecast by Disease Type
12.5 MEA Anti-Infective Vaccines Market Forecast by Bacterial Diseases
12.6 MEA Anti-Infective Vaccines Market Forecast by Viral Diseases
12.7 Middle East and Africa Anti-Infective Vaccines Market Forecast by Distribution Channel
12.8 GCC Anti-Infective Vaccines Market Forecast, 2021-2031
12.8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Anti-Infective Vaccines Market Forecast, 2021-2031
12.9 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031
12.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Anti-Infective Vaccines Market Forecast, 2021-2031
12.10 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031
12.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031
13 Company Profiles
13.1 Evotec
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis, 2015-2020
13.1.4 Product Benchmarking
13.1.5 Recent Developments
13.2 Merck & Co, Inc.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis, 2015-2020
13.2.4 Product Benchmarking
13.2.5 Recent Developments
13.3 GlaxoSmithKline plc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis, 2015-2020
13.3.4 Product Benchmarking
13.3.5 Recent Developments
13.4 Emergent BioSolutions Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis, 2015-2020
13.4.4 Product Pipeline
13.4.5 Recent Developments
13.5 Valneva SE
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis, 2015-2020
13.5.4 Product Benchmarking
13.5.5 Recent Developments
13.6 CSL Limited (Seqirus)
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis, 2015-2020
13.6.4 Product Benchmarking
13.6.5 Recent Developments
13.7 Pfizer
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis, 2015-2020
13.7.4 Product Benchmarking
13.7.5 Recent Developments
13.8 Serum Institute of India Pvt. Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.8.4 Recent Developments
13.9 BioDiem
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product Benchmarking
13.10 Mitsubishi Tanabe Pharma Corporation
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Pipeline
13.10.4 Recent Developments
13.11 Sinovac Biotech Ltd.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis, 2015-2020
13.11.4 Product Benchmarking
13.12 Bavarian Nordic
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis, 2015-2020
13.12.4 Product Benchmarking
13.12.5 Recent Developments
13.13 Berna Biotech Pharma GmbH
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Product Benchmarking
13.13.4 Recent Developments
13.14 Hookipa Pharma Inc.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Product Benchmarking
13.15 Syneos Health
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis, 2015-2020
13.15.4 Product Benchmarking
13.15.5 Recent Developments
14 Conclusion
14.1 Concluding Remarks
14.2 Recommendations
List of Tables
Table 1 Global Anti-Infective Vaccines Market Snapshot, 2021 & 2031 (US$ billion, CAGR %)
Table 2 Global Tuberculosis Incidences (Total of new and relapse cases and cases with unknown previous TB treatment history)
Table 3 Global Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 4 Global Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 5 Global Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 6 Global Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 7 Global Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 8 Global Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 9 Reported Cases of Polio (as of 2019) -
Table 10 Global Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 11 Global Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 12 Global Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 13 Global Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 14 Global Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 15 Global Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 16 Anti-Infective Vaccines Market Forecast for Live/Attenuated Vaccines, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 17 Anti-Infective Vaccines Market Forecast for Live/Attenuated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 18 Anti-Infective Vaccines Market Forecast for Live/Attenuated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 19 Anti-Infective Vaccines Market Forecast for Live/Attenuated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 20 Anti-Infective Vaccines Market Forecast for Live/Attenuated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 21 Anti-Infective Vaccines Market Forecast for Inactivated Vaccines, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 22 Anti-Infective Vaccines Market Forecast for Inactivated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 23 Anti-Infective Vaccines Market Forecast for Inactivated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 24 Anti-Infective Vaccines Market Forecast for Inactivated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 25 Anti-Infective Vaccines Market Forecast for Inactivated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 26 Anti-Infective Vaccines Market Forecast for DNA & Recombinant Vector Vaccines, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 27 Anti-Infective Vaccines Market Forecast for DNA & Recombinant Vector Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 28 Anti-Infective Vaccines Market Forecast for DNA & Recombinant Vector Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 29 Anti-Infective Vaccines Market Forecast for DNA & Recombinant Vector Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 30 Anti-Infective Vaccines Market Forecast for DNA & Recombinant Vector Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 31 Anti-Infective Vaccines Market Forecast for Others, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 32 Anti-Infective Vaccines Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 33 Anti-Infective Vaccines Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 34 Anti-Infective Vaccines Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 35 Anti-Infective Vaccines Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 36 Global Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 37 Anti-Infective Vaccines Market Forecast for Hospitals Clinics, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 38 Anti-Infective Vaccines Market Forecast for Hospitals Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 39 Anti-Infective Vaccines Market Forecast for Hospitals Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 40 Anti-Infective Vaccines Market Forecast for Hospitals Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 41 Anti-Infective Vaccines Market Forecast for Hospitals Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 42 Anti-Infective Vaccines Market Forecast for Public Hospitals, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 43 Anti-Infective Vaccines Market Forecast for Public Hospitals, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 44 Anti-Infective Vaccines Market Forecast for Public Hospitals, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 45 Anti-Infective Vaccines Market Forecast for Public Hospitals, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 46 Anti-Infective Vaccines Market Forecast for Public Hospitals, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 47 Anti-Infective Vaccines Market Forecast for Private Clinics, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 48 Anti-Infective Vaccines Market Forecast for Private Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 49 Anti-Infective Vaccines Market Forecast for Private Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 50 Anti-Infective Vaccines Market Forecast for Private Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 51 Anti-Infective Vaccines Market Forecast for Private Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 52 Anti-Infective Vaccines Market Forecast for Retail Pharmacies and Drug Stores, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 53 Anti-Infective Vaccines Market Forecast for Retail Pharmacies and Drug Stores, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 54 Anti-Infective Vaccines Market Forecast for Retail Pharmacies and Drug Stores, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 55 Anti-Infective Vaccines Market Forecast for Retail Pharmacies and Drug Stores, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 56 Anti-Infective Vaccines Market Forecast for Retail Pharmacies and Drug Stores, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 57 Anti-Infective Vaccines Market Forecast for E-commerce, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 58 Anti-Infective Vaccines Market Forecast for E-commerce, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 59 Anti-Infective Vaccines Market Forecast for E-commerce, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 60 Anti-Infective Vaccines Market Forecast for E-commerce, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 61 Anti-Infective Vaccines Market Forecast for E-commerce, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 62 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 63 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 64 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 65 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 66 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 67 North America Anti-Infective Vaccines Market Forecast by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 68 North America Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 69 North America Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 70 North America Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 71 North America Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 72 North America Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 73 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 74 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 75 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 76 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 77 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 78 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 79 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 80 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 81 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 82 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 83 Europe Anti-Infective Vaccines Market Forecast by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 84 Europe Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 85 Europe Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 86 Europe Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 87 Europe Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 88 Europe Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 89 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 90 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 91 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 92 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 93 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 94 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 95 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 96 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 97 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 98 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 99 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 100 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 101 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 102 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 103 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 104 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 105 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 106 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 107 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 108 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 109 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 110 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 111 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 112 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 113 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 114 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 115 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 116 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 117 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 118 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 119 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 120 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 121 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 122 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 123 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 124 Healthcare Spending Data for Asian Countries:
Table 125 incidences of various infective diseases across Asia-Pacific
Table 126 APAC Anti-Infective Vaccines Market Forecast by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 127 APAC Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 128 APAC Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 129 APAC Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 130 APAC Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 131 APAC Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 132 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 133 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 134 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 135 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 136 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 137 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 138 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 139 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 140 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 141 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 142 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 143 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 144 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 145 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 146 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 147 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 148 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 149 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 150 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 151 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 152 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 153 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 154 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 155 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 156 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 157 Incidences of various infective diseases across Latin America
Table 158 Latin America Healthcare Spending potential
Table 159 LATAM Anti-Infective Vaccines Market Forecast by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 160 LATAM Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 161 LATAM Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 162 LATAM Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 163 LATAM Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 164 LATAM Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 165 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 166 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 167 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 168 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 169 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 170 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 171 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 172 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 173 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 174 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 175 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 176 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 177 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 178 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 179 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 180 disease incidences in the African region
Table 181 MEA Anti-Infective Vaccines Market Forecast by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 182 MEA Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 183 MEA Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 184 MEA Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 185 MEA Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 186 MEA Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 187 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 188 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 189 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 190 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 191 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 192 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 193 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 194 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 195 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 196 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 197 Rest of MEA Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 198 Rest of MEA Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 199 Rest of MEA Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 200 Rest of MEA Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 201 Rest of MEA Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 202 Evotec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 203 Evotec: Product Benchmarking
Table 204 Evotec: Recent Developments
Table 205 Merck & Co, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 206 Merck & Co, Inc.: Product Benchmarking
Table 207 Merck & Co, Inc.: Recent Developments
Table 208 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 209 GlaxoSmithKline plc.: Product Benchmarking
Table 210 GlaxoSmithKline plc.: Recent Developments
Table 211 Emergent BioSolutions Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 212 Emergent BioSolutions Inc.: Product Pipeline
Table 213 Emergent BioSolutions Inc.: Recent Developments
Table 214 Valneva SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 215 Valneva SE: Product Benchmarking
Table 216 Valneva SE: Recent Developments
Table 217 CSL Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 218 CSL Limited: Product Benchmarking
Table 219 CSL Limited: Recent Developments
Table 220 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 221 Pfizer: Product Benchmarking
Table 222 Pfizer: Recent Developments
Table 223 Serum Institute of India Pvt. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 224 Serum Institute of India Pvt. Ltd.: Product Benchmarking
Table 225 Serum Institute of India Pvt. Ltd.: Recent Developments
Table 226 BioDiem: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 227 BioDiem: Product Benchmarking
Table 228 Mitsubishi Tanabe Pharma Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 229 Mitsubishi Tanabe Pharma Corporation: Product Pipeline
Table 230 Mitsubishi Tanabe Pharma Corporation: Recent Developments
Table 231 Sinovac Biotech Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 232 Sinovac Biotech Ltd.: Product Benchmarking
Table 233 Bavarian Nordic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 234 Bavarian Nordic: Product Benchmarking
Table 235 Bavarian Nordic: Recent Developments
Table 236 Berna Biotech Pharma GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 237 Berna Biotech Pharma GmbH: Product Benchmarking
Table 238 Berna Biotech Pharma GmbH: Recent Developments
Table 239 Hookipa Pharma Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 240 Hookipa Pharma Inc.: Product Benchmarking
Table 241 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 242 Syneos Health: Product Benchmarking
Table 243 Syneos Health: Recent Developments
List of Figures
Figure 1 Global Anti-Infective Vaccines Market: Market Segmentation
Figure 2 Global Anti-Infective Vaccines Market: Market Dynamics
Figure 3 Global Anti-Infective Vaccines Market: Market Trends
Figure 4 Global Anti-Infective Vaccines Market: SWOT Analysis
Figure 5 Porter’s Analysis
Figure 6 Global Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR %)
Figure 7 Global Anti-Infective Vaccines Market Share Forecast by Disease Type, 2021, 2026, 2031 (%)
Figure 8 Global Anti-Infective Vaccines Market for Bacterial Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 9 Global Anti-Infective Vaccines Market for Bacterial Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 10 Global Anti-Infective Vaccines Market for Bacterial Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 11 Global Anti-Infective Vaccines Market for Bacterial Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 12 Global Anti-Infective Vaccines Market for Bacterial Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 13 Global Anti-Infective Vaccines Market for Viral Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 14 Global Anti-Infective Vaccines Market for Viral Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 15 Global Anti-Infective Vaccines Market for Viral Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 16 Global Anti-Infective Vaccines Market for Viral Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 17 Global Anti-Infective Vaccines Market for Viral Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 18 Global Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR %)
Figure 19 Global Anti-Infective Vaccines Market Share Forecast by Product Type, 2021, 2026, 2031 (%)
Figure 20 Global Anti-Infective Vaccines Market for Live/Attenuated Vaccines Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 21 Global Anti-Infective Vaccines Market for Live/Attenuated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 22 Global Anti-Infective Vaccines Market for Live/Attenuated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 23 Global Anti-Infective Vaccines Market for Live/Attenuated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 24 Global Anti-Infective Vaccines Market for Live/Attenuated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 25 Global Anti-Infective Vaccines Market for Inactivated Vaccines Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 26 Global Anti-Infective Vaccines Market for Inactivated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 27 Global Anti-Infective Vaccines Market for Inactivated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 28 Global Anti-Infective Vaccines Market for Inactivated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 29 Global Anti-Infective Vaccines Market for Inactivated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 30 Global Anti-Infective Vaccines Market for DNA & Recombinant Vector Vaccines Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 31 Global Anti-Infective Vaccines Market for DNA & Recombinant Vector Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 32 Global Anti-Infective Vaccines Market for DNA & Recombinant Vector Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 33 Global Anti-Infective Vaccines Market for DNA & Recombinant Vector Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 34 Global Anti-Infective Vaccines Market for DNA & Recombinant Vector Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 35 Global Anti-Infective Vaccines Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 36 Global Anti-Infective Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 37 Global Anti-Infective Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 38 Global Anti-Infective Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 39 Global Anti-Infective Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 40 Global Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR %)
Figure 41 Global Anti-Infective Vaccines Market Share Forecast by Distribution Channel, 2021, 2026, 2031 (%)
Figure 42 Global Anti-Infective Vaccines Market for Hospital Clinics Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 43 Global Anti-Infective Vaccines Market for Hospital Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 44 Global Anti-Infective Vaccines Market for Hospital Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 45 Global Anti-Infective Vaccines Market for Hospital Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 46 Global Anti-Infective Vaccines Market for Hospital Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 47 Global Anti-Infective Vaccines Market for Public Hospitals Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 48 Global Anti-Infective Vaccines Market for Public Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 49 Global Anti-Infective Vaccines Market for Public Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 50 Global Anti-Infective Vaccines Market for Public Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 51 Global Anti-Infective Vaccines Market for Public Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 52 Global Anti-Infective Vaccines Market for Private Clinics Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 53 Global Anti-Infective Vaccines Market for Private Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 54 Global Anti-Infective Vaccines Market for Private Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 55 Global Anti-Infective Vaccines Market for Private Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 56 Global Anti-Infective Vaccines Market for Private Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 57 Global Anti-Infective Vaccines Market for Retail Pharmacies & Drug Stores Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 58 Global Anti-Infective Vaccines Market for Retail Pharmacies & Drug Stores Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 59 Global Anti-Infective Vaccines Market for Retail Pharmacies & Drug Stores Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 60 Global Anti-Infective Vaccines Market for Retail Pharmacies & Drug Stores Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 61 Global Anti-Infective Vaccines Market for Retail Pharmacies & Drug Stores Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 62 Global Anti-Infective Vaccines Market for E-Commerce Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 63 Global Anti-Infective Vaccines Market for E-Commerce Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 64 Global Anti-Infective Vaccines Market for E-Commerce Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 65 Global Anti-Infective Vaccines Market for E-Commerce Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 66 Global Anti-Infective Vaccines Market for E-Commerce Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 67 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ million)
Figure 68 Global Anti-Infective Vaccines Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 69 Global Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 70 Global Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 71 Global Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 72 Global Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 73 North America Anti-Infective Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 74 North America Anti-Infective Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 75 North America Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR%)
Figure 76 North America Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
Figure 77 North America Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ million, AGR%)
Figure 78 North America Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ million, AGR%)
Figure 79 North America Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 80 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 81 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 82 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 83 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 84 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 85 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 86 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 87 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 88 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 89 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 90 Europe Anti-Infective Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 91 Europe Anti-Infective Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 92 Europe Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR%)
Figure 93 Europe Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
Figure 94 Europe Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ million, AGR%)
Figure 95 Europe Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ million, AGR%)
Figure 96 Europe Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 97 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 98 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 99 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 100 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 101 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 102 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 103 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 104 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 105 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 106 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 107 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 108 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 109 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 110 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 111 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 112 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 113 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 114 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 115 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 116 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 117 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 118 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 119 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 120 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 121 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 122 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 123 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 124 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 125 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 126 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 127 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 128 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 129 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 130 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 131 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 132 Asia Pacific Anti-Infective Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 133 Asia Pacific Anti-Infective Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 134 Asia Pacific Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR%)
Figure 135 Asia Pacific Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
Figure 136 Asia Pacific Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ million, AGR%)
Figure 137 Asia Pacific Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ million, AGR%)
Figure 138 Asia Pacific Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 139 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 140 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 141 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 142 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 143 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 144 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 145 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 146 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 147 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 148 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 149 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 150 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 151 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 152 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 153 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 154 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 155 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 156 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 157 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 158 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 159 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 160 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 161 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 162 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 163 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 164 Latin America Anti-Infective Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 165 Latin America Anti-Infective Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 166 Latin America Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR%)
Figure 167 Latin America Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
Figure 168 Latin America Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ million, AGR%)
Figure 169 Latin America Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ million, AGR%)
Figure 170 Latin America Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 171 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 172 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 173 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 174 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 175 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 176 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 177 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 178 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 179 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 180 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 181 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 182 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 183 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 184 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 185 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 186 Middle East and Africa Anti-Infective Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 187 Middle East and Africa Anti-Infective Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 188 Middle East and Africa Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR%)
Figure 189 Middle East and Africa Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
Figure 190 MEA Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ million, AGR%)
Figure 191 MEA Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ million, AGR%)
Figure 192 Middle East and Africa Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 193 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 194 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 195 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 196 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 197 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 198 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 199 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 200 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 201 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 202 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 203 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 204 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 205 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 206 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 207 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 208 Evotec: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 209 Evotec: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 210 Evotec: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 211 Merck & Co, Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 212 Merck & Co, Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 213 Merck & Co, Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 214 GlaxoSmithKline plc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 215 GlaxoSmithKline plc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 216 GlaxoSmithKline plc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 217 Emergent BioSolutions Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 218 Emergent BioSolutions Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 219 Emergent BioSolutions Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 220 Valneva SE: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 221 Valneva SE: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 222 CSL Limited: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 223 CSL Limited: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 224 CSL Limited: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 225 Pfizer: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 226 Pfizer: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 227 Pfizer: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 228 Sinovac Biotech Ltd.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 229 Sinovac Biotech Ltd.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 230 Sinovac Biotech Ltd.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 231 Bavarian Nordic: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 232 Bavarian Nordic: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 233 Bavarian Nordic: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 234 Syneos Health: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 235 Syneos Health: Gross Profit, 2015-2020 (US$ million, AGR%)
Companies Profiled in the Report
Bavarian Nordic
Berna Biotech Pharma GmbH
BioDiem
CSL Limited (Seqirus)
Emergent BioSolutions Inc.
Evotec
GlaxoSmithKline plc.
Hookipa Pharma Inc.
Merck & Co, Inc.
Mitsubishi Tanabe Pharma Corporation
Pfizer
Serum Institute of India Pvt. Ltd.
Sinovac Biotech Ltd.
Syneos Health
Valneva SE
List of Other Companies
Astellas Pharmaceuticals
Bharat Immunologicals and Biologicals Corporation Limited
Binnopharm
Bio Farma
bioCSL
BiondVax
Bionor
Biremx
Dynavax
Krka Pharmaceuticals
MSD Pharmaceuticals
Serum Institute of India (SLL)
Shionogi Pharmaceuticals
Sinopharm
SmithKline Beecham
Vacsera
VaxInnate
VaxInnate Corporation
List of Organizations
Advisory Committee for Immunization Practices
Brazilian Ministry of Health
Butantan Institute
Cabtacuzino Institute
Center for Biologics Evaluation and Research
Centers for Disease Control and Prevention (CDC)
Centre for Disease Control and Prevention
Chemo-Sero-Therapeutic Research Institute
China National Biotech Group
China's National Regulatory Authority
Chinese Food and Drug Administration
ClearPath
CureVac
Medicago
Medicines and Healthcare products Regulatory Agency (MHRA)
MedImmune
Protein Science Corporation
Razi Institute
The Ministry of Health, Labour and Welfare, Japan
The Scripps Research Institute
Torlak Institut
Ultriks
US Department of Health and Human Services
WHO Strategic Advisory Group of Experts
World Health Organization
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
